Paragon 28 (FNA) Stock Price, News & Analysis

Company Overview

Paragon 28, Inc. (NYSE: FNA) is a medical device company specializing in comprehensive solutions for foot and ankle surgery. Headquartered in Englewood, Colorado, the company develops, manufactures, and markets a diverse range of implants, instruments and digital platforms to support orthopedic surgeons. Since its founding in 2019, Paragon 28 has focused on delivering clinically driven products designed to address both routine and complex pathologies of the lower extremity.

The company’s product portfolio includes plating systems, intramedullary nails, compression staples, external fixation devices and patient-specific instrumentation. Paragon 28 also offers proprietary digital preoperative planning and post-operative monitoring tools that allow surgeons to tailor treatment plans, optimize implant selection and track patient outcomes. These integrated solutions are intended to enhance surgical precision, reduce operating room time and improve overall case efficiency.

With a global footprint, Paragon 28 serves hospitals, ambulatory surgery centers and physician practices across North America, Europe, Asia-Pacific and the Middle East. The company distributes its products through a combination of direct sales teams and regional distribution partners, investing in clinical education programs, cadaver labs and advisory boards to support surgeon training and adoption. Paragon 28’s international expansion has been driven by strategic partnerships and targeted product launches aligned with regional regulatory requirements.

Under the leadership of President and Chief Executive Officer Michael Macioci, Paragon 28 emphasizes a culture of innovation and collaboration. The company’s executive team and board of directors include experienced professionals from the orthopedic and medical technology sectors. Paragon 28 continues to pursue research and development initiatives aimed at refining surgical workflows and advancing next-generation implant technologies, while maintaining close engagement with key opinion leaders and academic institutions.

Key Stats

• Today's Range: $13.07 to $13.11
• 50-Day Range: $13.11 to $13.11
• 52-Week Range: $4.65 to $13.13
• Volume: 19.38 million shs
• Average Volume: 1.17 million shs
• Market Capitalization: $1.10 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.75
• Consensus Rating: Hold

FNA Stock Analysis - Frequently Asked Questions

How have FNA shares performed this year?

Paragon 28's stock was trading at $10.33 on January 1st, 2025. Since then, FNA stock has increased by 26.9% and is now trading at $13.1050.

How were Paragon 28's earnings last quarter?

Paragon 28, Inc. (NYSE:FNA) released its quarterly earnings results on Thursday, March, 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.01. The company earned $71.75 million during the quarter, compared to analysts' expectations of $70.81 million. Paragon 28 had a negative net margin of 25.31% and a negative trailing twelve-month return on equity of 37.90%.

When did Paragon 28 IPO?

Paragon 28 (FNA) raised $125 million in an IPO on Friday, October 15th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. BofA Securities and Piper Sandler served as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

How do I buy shares of Paragon 28?

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Paragon 28 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Paragon 28 investors own include Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

• Last Earnings: 3/06/2025
• Today: 7/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:FNA
• CIK: 1531978
• Web: www.paragon28.com
• Phone: 720-912-1332
• Fax: N/A
• Employees: 343,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Paragon 28: $12.75
• High Price Target: $13.00
• Low Price Target: $12.00
• Potential Upside/Downside: -2.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.20
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.63)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$57.53 million
• Net Margins: -25.31%
• Pretax Margin: -26.58%
• Return on Equity: -37.90%
• Return on Assets: -18.22%

Debt

• Debt-to-Equity Ratio: 0.79
• Current Ratio: 3.50
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $256.18 million
• Price / Sales: 4.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.05 per share
• Price / Book: 6.39

Miscellaneous

• Outstanding Shares: 83,937,000
• Free Float: 70,894,000
• Market Cap: $1.10 billion
• Optionable: Optionable
• Beta: 1.47